UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, has developed a patented technology for delivery of an anti-COVID-19 formulation to the ocular surface to prevent and treat infections. The proprietary formulation combines a well-tolerated ocular chemistry with the Glint drug delivery contact lens to kill a … Continue reading Glint Pharmaceuticals to Begin Clinical Testing on Contact Lens to Prevent COVID-19 Virus Infection